HomeDealsNegotiationsPolicyPipelineMoneyPeopleDataThe WeekPharmTech 100Deal TrackerResearch
The Week

OpenAI launches biotech-specific AI model dubbed GPT-Rosalind

Following its recently announced partnership with Novo Nordisk, OpenAI is introducing a new reasoning model, GPT-Rosalind, to support research in biology, drug discovery and translational medicine.

By FierceBiotech · Apr 17, 2026 · via FierceBiotech
OpenAI launches biotech-specific AI model dubbed GPT-Rosalind

Image: FierceBiotech

Tags
theweekformat:headlineheadlineFierceBiotech
The Insider - Weekly pharma intelligence
Deals, negotiations, and policy analysis. Delivered when it matters.
No sponsored content. No noise. Unsubscribe anytime.
More from The Week
All The Week →
Opinion: The podcast bringing together MAHA and public health for hard conversations
The WeekSTAT News ↗
Opinion: The podcast bringing together MAHA and public health for hard conversations
“These sides aren't talking to each other. And there's a lot riding on it”: The hosts of “Why Should I Trust Y…
Apr 18, 2026
KFF Unveils “The Business of Health” Podcast with Chip Kahn
The WeekBriefing
KFF Unveils “The Business of Health” Podcast with Chip Kahn
KFF’s new weekly podcast debuts April 2026, diving into healthcare’s financial and policy mechanics, starting …
Apr 17, 2026
Vertical Integration Bends MLR Rules as Copay Maximizers Expand
The WeekBriefing
Vertical Integration Bends MLR Rules as Copay Maximizers Expand
Drug Channels’ April roundup highlights how vertical integration and copay maximizers are changing the economi…
Apr 17, 2026